VALIUM

This brand name is authorized in Australia, Brazil, Canada, Spain, France, Malta, Mexico, United States, South Africa

Active ingredients

The drug VALIUM contains one active pharmaceutical ingredient (API):

1 Diazepam UNII Q3JTX2Q7TU - DIAZEPAM

Diazepam is a psychotropic substance from the class of 1,4-benzodiazepines with marked properties of suppression of tension, agitation and anxiety as well as sedative and hypnotic effects. In addition, diazepam demonstrates muscle relaxant and anticonvulsive properties. It is used in the short-term treatment of anxiety and tension states, as a sedative and premedicant, in the control of muscle spasm and in the management of alcohol withdrawal symptoms. Read about Diazepam

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VALIUM Tablet	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05BA01	Diazepam	N Nervous system → N05 Psycholeptics → N05B Anxiolytics → N05BA Benzodiazepine derivatives
Discover more medicines within N05BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 3162K, 5072Y, 5356X
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 529206101112317, 529206102119315, 529206104111311, 529206105118311
Country: CA	Health Products and Food Branch	Identifier(s): 00013285
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 39409, 39905, 39943
Country: FR	Base de données publique des médicaments	Identifier(s): 60290800, 63196256, 67959261
Country: MT	Medicines Authority	Identifier(s): AA729/20503, AA729/20504
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 58834, 62019
Country: US	FDA, National Drug Code	Identifier(s): 0140-0004, 0140-0005, 0140-0006
Country: ZA	Health Products Regulatory Authority	Identifier(s): B/2.6/1003, B/2.6/1004, B/2.6/995